Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Immunomedics Inc (IMMU)

Immunomedics Inc (IMMU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,716,584
  • Shares Outstanding, K 231,144
  • Annual Sales, $ 300 K
  • Annual Income, $ -357,190 K
  • 60-Month Beta 3.42
  • Price/Sales 66,734.02
  • Price/Cash Flow N/A
  • Price/Book 33.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.25
  • Number of Estimates 4
  • High Estimate -0.18
  • Low Estimate -0.33
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +48.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.85 +125.52%
on 09/04/20
86.91 -1.78%
on 09/14/20
+43.77 (+105.24%)
since 08/25/20
3-Month
33.69 +153.37%
on 06/29/20
86.91 -1.78%
on 09/14/20
+50.24 (+143.02%)
since 06/25/20
52-Week
8.80 +870.00%
on 04/03/20
86.91 -1.78%
on 09/14/20
+70.13 (+460.47%)
since 09/25/19

Most Recent Stories

More News
4 Biotech Stocks to Own for the Rest of 2020

The healthcare sector has been led by the biotech and pharmaceutical industries. These industries have led the fight against COVID and cancer. Here are four biotech stocks that should continue to benefit...

AMGN : 243.82 (+1.46%)
ALXN : 114.43 (+2.15%)
IMMU : 85.36 (+0.07%)
Immunomedics' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor Immunomedics.

IMMU : 85.36 (+0.07%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts

Rigrodsky & Long, P.A. announces that it is investigating:

CBMG : 18.43 (+0.60%)
IMMU : 85.36 (+0.07%)
VRTU : 48.50 (-0.02%)
RST : 29.88 (unch)
Immunomedics Releases Trodelvy Data From Cancer Studies

Immunomedics (IMMU) releases data from different cancer studies on its lead drug, Trodelvy.

IMMU : 85.36 (+0.07%)
EBS : 101.63 (+2.54%)
ALIM : 5.05 (unch)
TECH : 241.74 (+4.10%)
Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

AZN : 55.51 (+2.47%)
PFE : 36.05 (+0.81%)
GILD : 62.25 (unch)
IMMU : 85.36 (+0.07%)
MRNS : 11.15 (+4.21%)
PTH : 133.23 (+3.83%)
WVE : 9.27 (-3.09%)
BBC : 38.84 (+2.72%)
BTEC : 46.67 (+2.96%)
NVUS : 0.9670 (+3.98%)
SAVA : 11.47 (+18.13%)
IDNA : 39.13 (+2.60%)
IBBJ : 25.86 (+2.02%)
MERGER ALERT - SBPH, IMMU, and MNTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

SBPH : 1.2800 (-5.19%)
IMMU : 85.36 (+0.07%)
MNTA : 52.40 (+0.02%)
(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?

, /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") breached...

GILD : 62.25 (unch)
IMMU : 85.36 (+0.07%)
Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy(TM) in Metastatic Urothelial Cancer

Trodelvy achieves a 27 percent overall response rate and a 5.9-month median duration of response in heavily-pretreated patients with metastatic urothelial cancer (mUC)

IMMU : 85.36 (+0.07%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Immunomedics, Inc. - IMMU

, /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in , is investigating Immunomedics,...

GILD : 62.25 (unch)
IMMU : 85.36 (+0.07%)
Williams-Sonoma, Tanger Factory Outlet, Gilead Sciences, Immunomedics and Jounce Therapeutics highlighted as Zacks Bull and Bear of the Day

Williams-Sonoma, Tanger Factory Outlet, Gilead Sciences, Immunomedics and Jounce Therapeutics highlighted as Zacks Bull and Bear of the Day

GILD : 62.25 (unch)
IMMU : 85.36 (+0.07%)
WSM : 86.86 (+0.13%)
SKT : 5.85 (-1.85%)
JNCE : 8.23 (+4.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IMMU with:

Business Summary

Immunomedics Inc. is a New Jersey-based biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. They have developed a number of advanced proprietary technologies that allow us to create humanized...

See More

Key Turning Points

2nd Resistance Point 85.59
1st Resistance Point 85.47
Last Price 85.36
1st Support Level 85.17
2nd Support Level 84.99

See More

52-Week High 86.91
Last Price 85.36
Fibonacci 61.8% 57.07
Fibonacci 50% 47.86
Fibonacci 38.2% 38.64
52-Week Low 8.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar